Pharmacological targeting of Sam68 functions in colorectal cancer stem cells
Summary: Cancer stem cells (CSCs) are documented to play a key role in tumorigenesis and therapy resistance. Despite significant progress in clinical oncology, CSC reservoirs remain elusive and difficult to eliminate. Reverse-turn peptidomimetics were characterized as disruptors of CBP/beta-Catenin...
Guardado en:
Autores principales: | Angelique N. Masibag, Christopher J. Bergin, Joshua R. Haebe, Aïcha Zouggar, Muhammad S. Shah, Tamara Sandouka, Amanda Mendes da Silva, François M. Desrochers, Aube Fournier-Morin, Yannick D. Benoit |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a4b364fa1b8740e1b8dceb3a7778dcb2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Emerging role of G9a in cancer stemness and promises as a therapeutic target
por: Joshua R. Haebe, et al.
Publicado: (2021) -
Sam68 promotes hepatic gluconeogenesis via CRTC2
por: Aijun Qiao, et al.
Publicado: (2021) -
Structural basis of RNA recognition and dimerization by the STAR proteins T-STAR and Sam68
por: Mikael Feracci, et al.
Publicado: (2016) - Biochemical pharmacology
- Pharmacology, biochemistry and behavior